Richard Kahn

Summary

Publications

  1. ncbi Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis
    Richard Kahn
    American Diabetes Association, Alexandria, VA, USA
    Lancet 375:1365-74. 2010
  2. ncbi Reducing the impact of diabetes: is prevention feasible today, or should we aim for better treatment?
    Richard Kahn
    University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Health Aff (Millwood) 31:76-83. 2012
  3. ncbi Metabolic syndrome: is it a syndrome? Does it matter?
    Richard Kahn
    American Diabetes Association, 1701 N Beauregard St, Alexandria, VA 22311, USA
    Circulation 115:1806-10; discussion 1811. 2007
  4. ncbi The impact of prevention on reducing the burden of cardiovascular disease
    Richard Kahn
    American Diabetes Association, Alexandria, VA, USA
    Circulation 118:576-85. 2008
  5. ncbi The impact of prevention on reducing the burden of cardiovascular disease
    Richard Kahn
    American Diabetes Association, Alexandria, Virginia, USA
    Diabetes Care 31:1686-96. 2008
  6. ncbi Metabolic syndrome--what is the clinical usefulness?
    Richard Kahn
    American Diabetes Association, Alexandria, VA 22307, USA
    Lancet 371:1892-3. 2008
  7. ncbi The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
    Richard Kahn
    American Diabetes Association, 1701 N Beauregard St, Alexandria, Virginia 22311, USA
    Diabetes Care 28:2289-304. 2005
  8. ncbi Commentary on the results and clinical implications of the PROactive study
    Robert Rizza
    American Diabetes Association, 1701 N. Beauregard Street, Alexandria, VA 22311, USA
    Diabetes Care 28:2965-7. 2005

Detail Information

Publications8

  1. ncbi Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis
    Richard Kahn
    American Diabetes Association, Alexandria, VA, USA
    Lancet 375:1365-74. 2010
    ..No clinical trials have assessed the effects or cost-effectiveness of sequential screening strategies to detect new cases of type 2 diabetes. We used a mathematical model to estimate the cost-effectiveness of several screening strategies...
  2. ncbi Reducing the impact of diabetes: is prevention feasible today, or should we aim for better treatment?
    Richard Kahn
    University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Health Aff (Millwood) 31:76-83. 2012
    ..In the meantime, once diabetes develops, we can greatly reduce the likelihood of serious complications through early detection and proper medical management...
  3. ncbi Metabolic syndrome: is it a syndrome? Does it matter?
    Richard Kahn
    American Diabetes Association, 1701 N Beauregard St, Alexandria, VA 22311, USA
    Circulation 115:1806-10; discussion 1811. 2007
  4. ncbi The impact of prevention on reducing the burden of cardiovascular disease
    Richard Kahn
    American Diabetes Association, Alexandria, VA, USA
    Circulation 118:576-85. 2008
    ..We therefore determined the effects of 11 nationally recommended prevention activities on CVD-related morbidity, mortality, and costs in the United States...
  5. ncbi The impact of prevention on reducing the burden of cardiovascular disease
    Richard Kahn
    American Diabetes Association, Alexandria, Virginia, USA
    Diabetes Care 31:1686-96. 2008
    ..We therefore determined the effects of 11 nationally recommended prevention activities on CVD-related morbidity, mortality, and costs in the U.S...
  6. ncbi Metabolic syndrome--what is the clinical usefulness?
    Richard Kahn
    American Diabetes Association, Alexandria, VA 22307, USA
    Lancet 371:1892-3. 2008
  7. ncbi The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
    Richard Kahn
    American Diabetes Association, 1701 N Beauregard St, Alexandria, Virginia 22311, USA
    Diabetes Care 28:2289-304. 2005
    ..quot; Until much needed research is completed, clinicians should evaluate and treat all CVD risk factors without regard to whether a patient meets the criteria for diagnosis of the "metabolic syndrome."..
  8. ncbi Commentary on the results and clinical implications of the PROactive study
    Robert Rizza
    American Diabetes Association, 1701 N. Beauregard Street, Alexandria, VA 22311, USA
    Diabetes Care 28:2965-7. 2005